Login to Your Account

Other News To Note

Thursday, September 29, 2011
Santen Pharmaceutical Co. Ltd., of Osaka, Japan, agreed to acquire shares representing 50.55 percent of the share capital of ophthalmology firm Novagali Pharma SA, of Paris, for a cash consideration of €6.15 (US$8.35), or about $136 million, marking a premium of 71.3 percent over the Sept. 27 trading price, which could be increased to €6.25.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription